Diagnostic Value of Platelet Endothelial Cell Adhesion Molecule-1 Combined with Serum Lipoprotein-associated Phospholipase A2 in Evaluating the Stability of Carotid Atherosclerotic Plaque

doi:10.12114/j.issn.1007-9572.2020.00.331

Abstract

Abstract: Background　The shedding and rupture of carotid atherosclerotic plaques are independent risk factors for acute stroke，but the stability of carotid atherosclerotic plaques lacks quantitative evaluation indicators.Objective　To explore the diagnostic value of platelet endothelial cell adhesion molecule-1 （PECAM-1/CD31）combined with serum lipoprotein-associated phospholipase A2 （Lp-PLA2）in evaluating the stability of carotid atherosclerotic plaque.Methods　139 patients with carotid atherosclerosis plaque admitted to Department of Neurology，the First Affiliated Hospital of Guangxi Medical University from October 2017 to March 2019 were enrolled，including 76 with unstable plaques and 63 with stable plaques detected by contrast-enhanced ultrasound.Gender，age，BMI，smoking，drinking，hypertension and atrial fibrillation prevalence，fasting plasma glucose（FPG），serum white blood count（WBC），red blood count（RBC），neutrophil count，platelet，creatinine，uric acid，fibrinogen，high-sensitivity C-reactive protein（hs-CRP），total cholesterol，triacylglycerol，high-density lipoprotein，low-density lipoprotein and Lp-PLA2，and PECAM-1/CD31were collected.The independent risk factors affecting the stability of carotid atherosclerotic plaque were screened out by multivariate Logistic regression analysis，and the ROC curve of the indicator，either alone or in combination，was established to evaluate the efficiency in evaluating the stability of carotid atherosclerotic plaque.Results　The prevalence of smoking and atrial fibrillation，average levels of hs-CRP，total cholesterol，triacylglycerol，high-density lipoprotein，low-density lipoprotein，PECAM-1 / CD31，and Lp-PLA2 in unstable plaque group were higher than those of stable plaque group（P<0.05）.Multivariate Logistic regression analysis showed that low-density lipoprotein 〔OR=2.453，95%CI（2.322，2.591）〕，PECAM-1/CD31 〔OR=1.372，95%CI（1.166，1.614）〕and Lp-PLA2〔OR=1.827，95%CI（1.565，2.133）〕were associated with the occurrence of unstable carotid atherosclerotic plaques（P<0.05）.PECAM-1 / CD31（r=0.090，P=0.031）and Lp-PLA2（r=0.090，P=0.005）were significantly positively correlated with low-density lipoprotein.The area under the ROC curve（AUC）of PECAM-1 / CD31 for the diagnosis of stability of carotid atherosclerotic plaque was 0.686〔95%CI（0.224，0.405）〕，when the optimal cut-off point was determined as 11.050 mg / L，with 77.60% sensitivity and 60.30% specificity.The AUC of Lp-PLA2 was 0.724〔95%CI（0.189，0.364）〕，when the optimal cut-off point was determined as 176.585 mg / L，with 98.70% sensitivity and 47.60% specificity.And the AUC of PECAM-1 / CD31 in combination with Lp-PLA2 was 0.875〔95%CI（0.112，0.254）〕，when the optimal cut-off point was determined as 125.28 mg / L，with a sensitivity of 89.50%，and a specificity of 83.20%.Conclusion　Either PECAM-1 / CD31 or Lp-PLA2 showed efficiency in diagnosing unstable carotid atherosclerotic plaque.The combination of the two showed higher value，which may be used as a quantitative diagnostic indicator.

Key words: Atherosclerosis, Carotid atherosclerotic plaque, Latelet endothelial cell adhesion molecule l, Lipoprotein Associated Phospholipase A2, Ischemic stroke

摘要： 背景　颈动脉粥样硬化斑块的脱落及破裂出血是诱发急性脑卒中的独立危险因素，但是关于颈动脉粥样硬化斑块的稳定性尚缺乏定量的评估指标。目的　探究血小板内皮细胞黏附分子1（PECAM-l/CD31）联合血清脂蛋白相关磷脂酶A2（Lp-PLA2）对颈动脉粥样硬化斑块稳定性的诊断价值。方法　选择2017年10月—2019年3月广西医科大学第一附属医院神经内科收治颈动脉粥样硬化斑块患者139例作为研究对象，根据超声造影检查结果，分为不稳定斑块组（76例）和稳定斑块组（63例），记录两组患者的性别、年龄、体质指数（BMI）、吸烟、饮酒、高血压、心房颤动情况，并检测其空腹血糖、白细胞计数、红细胞计数、中性粒细胞计数、血小板计数、血肌酐、尿酸、纤维蛋白原、超敏C反应蛋白、总胆固醇、三酰甘油、高密度脂蛋白、低密度脂蛋白、PECAM-1/CD31 、Lp-PLA2水平。采用多因素Logistics回归分析筛选出影响颈动脉粥样硬化斑块稳定性的独立危险因素，建立各指标的受试者工作特征（ROC）曲线，评估各指标及联合指标对颈动脉不稳定斑块的诊断效能。结果　不稳定斑块组吸烟比例、心房颤动比例及超敏C反应蛋白、总胆固醇、三酰甘油、高密度脂蛋白、低密度脂蛋白、PECAM-1/CD31 、Lp-PLA2水平高于稳定斑块组（P<0.05）。多因素Logistic回归分析结果显示，低密度脂蛋白〔OR=2.453，95%CI（2.322，2.591）〕、PECAM-1/CD31 〔OR=1.372，95%CI（1.166，1.614）〕和Lp-PLA2〔OR=1.827，95%CI（1.565，2.133）〕是颈动脉不稳定斑块发生的影响因素（P<0.05）。PECAM-1/CD31（r=0.090，P=0.031）、Lp-PLA2（r=0.090，P=0.005）与低密度脂蛋白呈正相关。PECAM-1/CD31诊断颈动脉粥样硬化斑块稳定性的ROC曲线下面积（AUC）为0.686〔95%CI（0.224，0.405）〕，最佳诊断点为11.050 mg/L，灵敏度为77.60%，特异度为60.30%；Lp-PLA2的AUC为0.724〔95%CI（0.189，0.364）〕，最佳诊断点为176.585 mg/L，其灵敏度为98.70%，特异度为47.60%；而两者联合诊断颈动脉不稳定斑块的AUC为0.875〔95%CI（0.112，0.254）〕，最佳诊断点为125.28 mg/L，其灵敏度为89.50%，特异度为83.20%。结论　PECAM-1/CD31和Lp-PLA2对颈动脉不稳定斑块具有一定的诊断价值，两者联合诊断价值较高，可作为颈动脉不稳定斑块的定量诊断指标。

关键词: 动脉粥样硬化, 颈动脉粥样硬化斑块, 血小板内皮细胞黏附分子1, 脂蛋白相关磷脂酶 A2, 缺血性脑卒中

HUANG Liqiang,CHENG Daobin,YE Ziming, et al. Diagnostic Value of Platelet Endothelial Cell Adhesion Molecule-1 Combined with Serum Lipoprotein-associated Phospholipase A2 in Evaluating the Stability of Carotid Atherosclerotic Plaque　[J]. Chinese General Practice, 2021, 24(2): 170-175. DOI: 10.12114/j.issn.1007-9572.2020.00.331.
黄利强,程道宾,叶子明等. 血小板内皮细胞黏附分子1联合血清脂蛋白相关磷脂酶A2对颈动脉粥样硬化斑块稳定性的诊断价值[J]. 中国全科医学, 2021, 24(2): 170-175. DOI: 10.12114/j.issn.1007-9572.2020.00.331.

References

［1］BATOOL F，SULTAN W，ZULFIQAR A.Carotid atherosclerosis occurrence as a leading factor of ischemic stroke and important disease marker［J］．Indo Am J pharm sci，2018，5（6）：4986-4990．DOI：10.5281/zenodo.1286241.
［2］MURY P，CHIRICO E N，MURA M，et al．Oxidative stress and inflammation，key targets of atherosclerotic plaque progression and vulnerability：potential impact of physical activity［J］．Sports Med，2018，48（12）：2725-2741．DOI：10.1007/s40279-018-0996-z.
［3］SABA，SAAM T，JÄGER H R，et al．Imaging biomarkers of vulnerable carotid plaques for stroke risk prediction and their potential clinical implications［J］．Lancet Neurol，2019，18（6）：559-572．DOI：10.1016/S1474-4422（19）30035-3.
［4］SABA L，JAIN P K，SURI H S，et al．Plaque tissue morphology-based stroke risk stratification using carotid ultrasound：a polling-based PCA learning paradigm［J］．J Med Syst，2017，41（6）：98．DOI：10.1007/s10916-017-0745-0.
［5］凌翔.超声检测颈动脉斑块与脑梗死发生率的相关性［J］．中国全科医学，2018，21（z1）：277-278．DOI：10.3969/j.issn.1007-9572.2018.z1.119.
［6］CHEN L L，YANG Q H，DING R，et al．Carotid thickness and atherosclerotic plaque stability，serum inflammation，serum MMP-2 and MMP-9 were associated with acute cerebral infarction［J］．Exp Ther Med，2018，16（6）：5253-5257．DOI：10.3892/etm.2018.6868.
［7］GASBARRINO K，ZHENG H E，HAFIANE A，et al．Decreased adiponectin-mediated signaling through the AdipoR2 pathway is associated with carotid plaque instability［J］．Stroke，2017，48（4）：915-924．DOI：10.1161/STROKEAHA.116.015145.
［8］ MESNIER J，SAYAH N，RASSER C，et al．P4593Stent coating with a CD31-mimetic peptide allows effective endothelialization while reducing local thrombosis and inflammation in pig coronary arteries in vivo［J］．Eur Heart J，2018，39（suppl_1）．DOI：10.1093/eurheartj/ehy563.p4593.
［9］AKINKUOLIE A O，LAWLER P R，CHU A Y，et al．Group ⅡA secretory phospholipase A2，vascular inflammation，and incident cardiovascular disease［J］．Arterioscler Thromb Vasc Biol，2019，39（6）：1182-1190.
［10］PAN G Z，KOU L J，WU Y，et al．Regulation of lipoprotein-associated phospholipase A2 silencing on myocardial fibrosis in mice with coronary atherosclerosis［J］．Biochem Biophys Res Commun，2019，514（2）：450-455．DOI：10.1016/j.bbrc.2019.04.129.
［11］于博文，武琛，薛哲，等．颈动脉超声造影评价动脉粥样硬化斑块内新生血管水平的应用价值［J］．中国现代神经疾病杂志，2019，19（3）：192-198.
［12］VAN DIJK A C，TRUIJMAN M T，HUSSAIN B，et al．Intraplaque hemorrhage and the plaque surface in carotid atherosclerosis：the plaque at RISK study（PARISK）［J］．AJNR Am J Neuroradiol，2015，36（11）：2127-2133.
［13］VIGNE J，BAY S，AID-LAUNAIS R，et al．Cleaved CD31 as a target for in vivo molecular imaging of inflammation［J］．Sci Rep，2019，9（1）：19560．DOI：10.1038/s41598-019-56163-x.
［14］WANG Y，SONG H Q，MENG R，et al．Abstract TP120：elevated lipoprotein-associated phospholipase A2 is differentially associated with symptomatic intracranial atherosclerosis［J］．Stroke，2018，49（Suppl_1）．DOI：10.1161/str.49.suppl_1.tp120.
［15］MARKSTAD H，EDSFELDT A，YAO MATTISON I，et al．High levels of soluble lectinlike oxidized low-density lipoprotein receptor-1 are associated with carotid plaque inflammation and increased risk of ischemic stroke［J］．J Am Heart Assoc，2019，8（4）：e009874．DOI：10.1161/JAHA.118.009874.
［16］WANG C X，FANG X H，HUA Y，et al．Lipoprotein-associated phospholipase A2 and risk of carotid atherosclerosis and cardiovascular events in community-based older adults in China［J］．Angiology，2018，69（1）：49-58．DOI：10.1177/0003319717704554.
［17］ZHANG Q，LIU S M，LIU Y M，et al．Achieving low density lipoprotein-cholesterol<70 mg/dL may be associated with a trend of reduced progression of carotid artery atherosclerosis in ischemic stroke patients［J］．J Neurol Sci，2017，378：26-29．DOI：10.1016/j.jns.2017.04.024.
［18］HU G F，LIU D P，TONG H Y，et al．Lipoprotein-associated phospholipase A2 activity and mass as independent risk factor of stroke：a meta-analysis［J］．Biomed Res Int，2019，2019：8642784．DOI：10.1155/2019/8642784.
［19］SAKELLARIOS A I，BIZOPOULOS P，PAPAFAKLIS M I，et al．Natural history of carotid atherosclerosis in relation to the hemodynamic environment［J］．Angiol，2017，68（2）：109-118．DOI：10.1177/0003319716644138.
［20］ZHANG M M，ZHANG C G，YANG C J，et al．The association between the D166E polymorphism of the lipoprotein associated phospholipase A2 and risk of myocardial infarction［J］．Eur Rev Med Pharmacol Sci，2019，23（9）：3960-3966．DOI：10.26355/eurrev_201905_17825.
［21］DE MAURI A，VIDALI M，CHIARINOTTI D，et al．Lipoprotein-associated phospholipase A2 predicts cardiovascular events in dialyzed patients［J］．J Nephrol，2019，32（2）：283-288．DOI：10.1007/s40620-018-0521-3.

[1]	XIANG Xinyue, ZHANG Bingqing, OUYANG Yuqin, TANG Wenjuan, FENG Wenhuan. Impact of Short-term Medical Weight Loss on Atherosclerotic Cardiovascular Disease Risk in Patients with Obesity [J]. Chinese General Practice, 2025, 28(26): 3229-3239.
[2]	GAO Haijun, REN Jiayu, WANG Ruolin, ZHOU Huiya, QU Peng. Research Progress on the Role of Endothelial Cell Injury and Dysfunction in Atherosclerosis [J]. Chinese General Practice, 2025, 28(21): 2697-2704.
[3]	CHU Tianyu, GU Yan. Carotid Artery Calcification Features in Plaque Stability and Clinical Events [J]. Chinese General Practice, 2025, 28(18): 2247-2252.
[4]	GU Keyi, PAN Yaojia, HAN Zheng, FU Xiaoya, GU Handong, YANG Fei, WANG Weiqiang. Correlation between Different Obesity Metabolic Phenotypes and Atherosclerosis in a Young Population: Uric Acid as Its Potential Factor [J]. Chinese General Practice, 2025, 28(07): 831-837.
[5]	CHEN Ling, XU Rui, CHENG Xinchun, ZHANG Zhanying, XU Hong. Mechanism of Liraglutide in Oxidized Low-density Lipoprotein Induced Endothelial Cell Injury Based on NOD-like Receptor 3 Inflammasome Pathway [J]. Chinese General Practice, 2025, 28(05): 601-606.
[6]	LIU Zuting, XU Minghuan, YANG Xuezhi, MO Jiali, LIU Xingyu, DU Huijie, ZHANG Huiqin, YI Yingping, KUANG Jie. Correlation between the Systemic Inflammatory Response Index and Risk of Ischemic Stroke Recurrence [J]. Chinese General Practice, 2025, 28(05): 541-547.
[7]	DU Huijie, LIU Xingyu, XU Minghuan, YANG Xuezhi, ZHANG Huiqin, MO Jiali, LU Yi, KUANG Jie. Advances in the Prognostic Prediction of Acute Ischemic Stroke: Using Machine Learning Predictive Models as an Example [J]. Chinese General Practice, 2025, 28(05): 554-560.
[8]	YUAN Dan, WANG Ying, WANG Yingpeng, XU Li, XUE Jia, CHENG Jingjing, WANG Haipeng. Effect of the Remote Ischemic Postconditioning on the Prognosis of Patients with Acute Ischemic Stroke beyond Time Window: a Randomized Controlled Trial [J]. Chinese General Practice, 2025, 28(02): 169-174.
[9]	REN Xiaoqiao, WANG Pan, WU Hao, JI Yong, SHI Zhihong. Correlation of Serum Uric Acid to Serum Creatinine Ratio with the Recurrence of Cerebrovascular Events and Mortality in Patients with Acute Cerebrovascular Disease: a Prospective Cohort Study [J]. Chinese General Practice, 2025, 28(02): 175-182.
[10]	LI Jie, DING Hu. Latest Progress of Lipoprotein (a) in Cardiovascular Diseases [J]. Chinese General Practice, 2024, 27(36): 4505-4514.
[11]	GAO Lan, ZHANG Xiangning, XIE Haotai, FAN Fangfang, JIA Jia, LI Jianping, MA Wei, ZHANG Yan. Influencing Factors for Subendocardial Viability Ratio in the Community Population [J]. Chinese General Practice, 2024, 27(36): 4554-4560.
[12]	ZHANG Jun, LUO Wen, WANG Luya, YANG Ya, CHEN Yan. Exploration and Practice of the Construction of Outpatient Model for Blood Lipid Management in Comprehensive Hospitals [J]. Chinese General Practice, 2024, 27(36): 4527-4533.
[13]	LUO Sifu, JIN Menglong, SUBINUER· Jureti, LIU Ziyang, FU Zhenyan. Study on the Efficacy Differences of Moderate-dose Statin Therapy in Patients with Atherosclerotic Cardiovascular Disease among Different Ethnic Groups [J]. Chinese General Practice, 2024, 27(36): 4522-4526.
[14]	LIU Zhongdian, XU Qi, CHEN Yijing, QIN Lingqiao, CHEN Shuping, TANG Weiting, ZHONG Qiuan. Identification of Carotid Atherosclerosis in Medium-high Risk Population of Cardiovascular Disease: Prediction Model and Validation Based on Machine Learning [J]. Chinese General Practice, 2024, 27(30): 3763-3771.
[15]	LIU Xingyu, DU Huijie, MO Jiali, XU Minghuan, LIU Zuting, YANG Xuezhi, ZHANG Huiqin, YI Yingping, KUANG Jie. Correlation between Remnant Cholesterol and the Risk of Ischemic Stroke Recurrence and Its Predictive Value [J]. Chinese General Practice, 2024, 27(26): 3227-3231.